As living standards improve, the rise in medical expenses due to an aging population becomes evident. The outbreak of COVID-19 has significantly heightened health awareness among the Chinese population, leading to an escalating demand for medical treatments. The diverse and excellent properties of medical plastics position them well to meet the varied needs of the expanding medical industry. Recent data reveals that China's medical device market reached an impressive RMB 957.34 billion in 2022. Notably, the high-value medical consumables market constituted 16.43%, with a market size of approximately RMB 157.306 billion. Looking ahead, with improved residents' ability to afford medical care, government support for the medical industry, and technological advancements upgrading the sector, China's medical device industry is expecting sustained rapid growth. Predictions indicate that by 2023, the medical device market in China will reach RMB 1056.4 billion, and high-value medical consumables will exceed RMB 170 billion. By 2030, the market is anticipated to surpass RMB 2.2 trillion (approximately USD 320 billion), potentially making China the world's largest medical device market.

In response to the surging market demand for medical devices and consumables, FCS Group introduces the CT-280R All-electric Multi-component Injection Molding Machine. This innovation is tailored to meet the evolving needs of enterprises in the medical treatment and supplies industry, emphasizing clean production environments, high efficiency, yield, and energy conservation. FCS Group showcased the PET Blood Vessel Injection Molding Machine at the Adsale exhibition this year, characterized by faster start-up speeds, higher precision, lower energy consumption, and won recognition from on-site users.

FCS CT-280R All-electric Multi-component Injection Molding Machine Has the Following Features:

• The injection/storage adopts servo motor, and has two or more independent tube groups, enabling simultaneous injection and greatly reducing the molding cycle.
• The speed of the servo rotary table is increased by 30% to 50%, and the accuracy of the positioning system is 0.005°.
• The injection seat features a wire rail that reduces feeding back pressure to almost 0, effectively reducing glue overflow from the nozzle or hot runner.
• The machine is equipped with European top-level servo drive system and controller, with an injection control accuracy of up to 0.01mm.

FCS Group's injection molding machines are dedicated to constructing digital and intelligent integrated service solutions for medical product manufacturers and other industries. These solutions empower enterprises to respond rapidly and flexibly to production requirements in a low-risk, high-precision, and cost-effective manner. The machines not only reduce costs but also enhance efficiency, improve product quality, facilitate rapid delivery, decrease carbon emissions, and elevate the overall competitiveness and influence of enterprises through intelligent and digital transformation.